Evidence map›Paper›PMID 19748740›Full record

ArticlePain2009

Role of SIP30 in the development and maintenance of peripheral nerve injury-induced neuropathic pain.

Yu-Qiu Zhang, Ning Guo, Guangdun Peng, Xidao Wang, Mei Han, Jeremy Raincrow, Chi-hua Chiu, Lique M Coolen, Robert J Wenthold, Zhi-Qi Zhao and 2 more

Erratum issuedAbstract read
In one paragraph

Article in Pain, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. SIP30 involvement in vesicle exocytosis from PC12 cells.Biochemistry and biophysics reports · 2024
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. DNMT3a methylation in neuropathic pain.Journal of pain research · 2017
    Article
  11. Article
  12. Article
  13. SIP30 is required for neuropathic pain-evoked aversion in rats.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2014
    Article
  14. Moonlighting functions of the NRZ (mammalian Dsl1) complex.Frontiers in cell and developmental biology · 2014
    Review
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

  • Erratum issued
    Wang, Xidao [added]
5 · Who and what money

Authors and funding

12 authors at 5 institutions in 2 countries.

Yu-Qiu ZhangDepartment of Cell Biology, Neurobiology and Anatomy, University of Cincinnati College of Medicine, Cincinnati, OH, USA.
Ning Guo
Guangdun Peng
Xidao Wang
Mei Han
Jeremy Raincrow
Chi-hua Chiu
Lique M Coolen
Robert J Wenthold
Zhi-Qi Zhao
Naihe Jing
Lei Yu
Fudan University · CNRutgers, The State University of New Jersey · USShanghai Institutes for Biological Sciences · CNUniversity of Cincinnati Medical Center · USNational Institute on Deafness and Other Communication Disorders · US

Funding

Opioid Receptor Polymorphism &PD Drug ResponseR01DA013471 · NIDA · UNIVERSITY OF CINCINNATI · PI YU, LEI · 2001 to 2005
$1.7M
Human genetic polymorphism impact in a mouse modelR21DA020555 · NIDA · RUTGERS, THE STATE UNIV OF N.J. · PI YU, LEI · 2006 to 2007
$304k
NIDA NIH HHS DA013471NIDA NIH HHS DA020555NIDA NIH HHS R01 DA013471NIDA NIH HHS R21 DA020555
6 · The paper itself

Abstract

Using the chronic constriction injury (CCI) model of neuropathic pain, we profiled gene expression in the rat spinal cord, and identified SIP30 as a gene whose expression was elevated after CCI. SIP30 was previously shown to interact with SNAP25, but whose function was otherwise unknown. We now show that in the spinal cord, SIP30 was present in the dorsal horn laminae where the peripheral nociceptive inputs first synapse, co-localizing with nociception-related neuropeptides CGRP and substance P. With the onset of neuropathic pain after CCI surgery, SIP30 mRNA and protein levels increased in the ipsilateral side of the spinal cord, suggesting a potential association between SIP30 and neuropathic pain. When CCI-upregulated SIP30 was inhibited by intrathecal antisense oligonucleotide administration, neuropathic pain was attenuated. This neuropathic pain-reducing effect was observed both during neuropathic pain onset following CCI, and after neuropathic pain was fully established, implicating SIP30 involvement in the development and maintenance phases of neuropathic pain. Using a secretion assay in PC12 cells, anti-SIP30 siRNA decreased the total pool of synaptic vesicles available for exocytosis, pointing to a potential function for SIP30. These results suggest a role of SIP30 in the development and maintenance of peripheral nerve injury-induced neuropathic pain.

Indexed as

AnimalsBlotting, WesternChromosomal Proteins, Non-HistoneChronic DiseaseConstriction, PathologicExocytosisHot TemperatureImmunohistochemistryMaleMotor ActivityNerve Tissue ProteinsOligonucleotides, AntisensePainPain MeasurementPeripheral NervesPeripheral Nervous System DiseasesChromosomal Proteins, Non-HistoneNerve Tissue ProteinsOligonucleotides, AntisenseRNAZwint protein, rat

Identifiers

PMID19748740
PMCPMC2760650
OpenAlexW2088766573

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.